(1 - 20 von 27
)
Amgen Files For FDA Approval Of Panitumumab – Update – Oral Cancer...
oralcancernews.org
Willard Dere, chief medical officer and senior vice president of Global Development at Amgen, said, “Completing the BLA brings us one step ...
Amgen to start phase 3 trial to evaluate impact of treating anaemia ...test.pharmabiz.com › news › amgen-to-start-phase-3...
test.pharmabiz.com
... recently completed Phase 2 pilot studies of anaemia treatment in heart failure patients which provided us with encouraging results," said Willard Dere, ...
Amgen wins expanded European licence for cancer drug Vectibix - PMLiVE
www.pmlive.com
EMA approves drug as a primary treatment for colorectal cancer - PMLiVE
History of Changes for Study: NCT ClinicalTrials.govclinicaltrials.gov › history › NCT
clinicaltrials.gov
Study Officials: Willard Dere, M.D.. Study Chair Amgen. Locations: Open or close this module IPDSharing. Plan to Share IPD: Open or close this module ...
sortiert nach Relevanz / Datum